 | AFAP1-AS1 | LncRNA | miR-145 | HOXA1 | Homo sapiens (human) | Oral Squamous Cell Cancer | 33650645 |
| anti-miR-145 | Artifically engineered RNA | miR-145 | TIRAP | Homo sapiens (human) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-145 | Artifically engineered RNA | miR-145 | TRAF6 | Homo sapiens (human) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-145 | Artifically engineered RNA | miR-145 | TIRAP | Mus musculus (mouse) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-145 | Artifically engineered RNA | miR-145 | TRAF6 | Mus musculus (mouse) | 5Q-Syndrome Phenotype | 19898489 |
| Circ-ITCH | Circular RNA | miR-145 | RASA1 | Homo sapiens (human) | Ovarian Cancer | 30243714 |
| CircEPSTI1 | Circular RNA | miR-145 | HMGB3 | Homo sapiens (human) | Non-Small Cell Lung Cancer | 32801908 |
| CircRILPL1 | Circular RNA | miR-145 | IGF1R | Homo sapiens (human) | Myoblast Proliferation And Apoptosis | 33542215 |
| CircRILPL1 | Circular RNA | miR-145 | PI3K | Homo sapiens (human) | Myoblast Proliferation And Apoptosis | 33542215 |
| CircRILPL1 | Circular RNA | miR-145 | AKT | Homo sapiens (human) | Myoblast Proliferation And Apoptosis | 33542215 |
| Circ_001569 | Circular RNA | miR-145 | E2F5 | Homo sapiens (human) | Colorectal Cancer | 27058418 |
| Circ_001569 | Circular RNA | miR-145 | BAG4 | Homo sapiens (human) | Colorectal Cancer | 27058418 |
| Circ_001569 | Circular RNA | miR-145 | FMNL2 | Homo sapiens (human) | Colorectal Cancer | 27058418 |
| CRNDE | LncRNA | miR-145 | E2F3 | Homo sapiens (human) | Bladder Cancer | 29710461 |
| CRNDE | LncRNA | miR-145 | E2F3 | Homo sapiens (human) | Gastric Cancer | 28490034 |
| LET | LncRNA | miR-145 | TGFb1 | Homo sapiens (human) | Bladder Cancer | 28839463 |
| Linc-ROR | LncRNA | miR-145 | SOX9 | Homo sapiens (human) | Mesenchymal Stem Cell(Bmscs) Chondrogenesis | 33485931 |
| LINC00184 | LncRNA | miR-145 | ANGPT2 | Homo sapiens (human) | Gastric Cancer | 33758610 |
| LINC00707 | LncRNA | miR-145 | CDCA3 | Homo sapiens (human) | Dder Cancer | 34192702 |
| lincRNA-ROR | LncRNA | miR-145 | ARF6 | Homo sapiens (human) | Breast Cancer | 25253741 |
| lincRNA-ROR | LncRNA | miR-145 | MUC1 | Homo sapiens (human) | Breast Cancer | 29673594 |
| lincRNA-ROR | LncRNA | miR-145 | TNBC | Homo sapiens (human) | Breast Cancer | 25253741 |
| lincRNA-ROR | LncRNA | miR-145 | ARF6 | Homo sapiens (human) | Breast Cancer | 25253741 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Breast Cancer | 28869448 |
| lincRNA-ROR | LncRNA | miR-145 | Sox2 | Homo sapiens (human) | Colon Cancer | 29690669 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Colon Cancer | 29690669 |
| lincRNA-ROR | LncRNA | miR-145 | OCT4 | Homo sapiens (human) | Colon Cancer | 29690669 |
| lincRNA-ROR | LncRNA | miR-145 | NA | Homo sapiens (human) | Colon Cancer | 27071407 |
| lincRNA-ROR | LncRNA | miR-145 | p53 | Homo sapiens (human) | Colorectal Cancer | 27696511 |
| lincRNA-ROR | LncRNA | miR-145 | OCT4 | Homo sapiens (human) | Endometrial Cancer | 24589415 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Endometrial Cancer | 24589415 |
| lincRNA-ROR | LncRNA | miR-145 | Sox2 | Homo sapiens (human) | Endometrial Cancer | 24589415 |
| lincRNA-ROR | LncRNA | miR-145 | FSCN1 | Homo sapiens (human) | Esophageal Squamous Cancer | 29430188 |
| lincRNA-ROR | LncRNA | miR-145 | KLF4 | Homo sapiens (human) | Gastric Cancer | 29719612 |
| lincRNA-ROR | LncRNA | miR-145 | RAD18 | Homo sapiens (human) | Hepatocellular Carcinoma | 29559320 |
| lincRNA-ROR | LncRNA | miR-145 | ZEB2 | Homo sapiens (human) | Hepatocellular Carcinoma | 28680141 |
| lincRNA-ROR | LncRNA | miR-145 | OCT4 | Homo sapiens (human) | Lung Cancer | 28516515 |
| lincRNA-ROR | LncRNA | miR-145 | Sox2 | Homo sapiens (human) | Lung Cancer | 28516515 |
| lincRNA-ROR | LncRNA | miR-145 | FSCN1 | Homo sapiens (human) | Lung Cancer | 28388536 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Pancreatic Cancer | 26636540 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Pancreatic Cancer | 26636540 |
| lincRNA-ROR | LncRNA | miR-145 | TGFB | Homo sapiens (human) | Papillary Thyroid Cancer | 29280051 |
| lincRNA-ROR | LncRNA | miR-145 | OCT4 | Homo sapiens (human) | Prostate Cancer | 28843521 |
| lincRNA-ROR | LncRNA | miR-145 | OCT4 | Homo sapiens (human) | Stem Cell Self-Renewal | 23541921 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Homo sapiens (human) | Stem Cell Self-Renewal | 23541921 |
| lincRNA-ROR | LncRNA | miR-145 | Sox2 | Homo sapiens (human) | Stem Cell Self-Renewal | 23541921 |
| lincRNA-ROR | LncRNA | miR-145 | NA | Homo sapiens (human) | Stem Cell Self-Renewal | 24589415 |
| lincRNA-ROR | LncRNA | miR-145 | ARF6 | Mus musculus (mouse) | Breast Cancer | 25253741 |
| lincRNA-ROR | LncRNA | miR-145 | Nanog | Mus musculus (mouse) | Pancreatic Cancer | 26636540 |
| MALAT1 | LncRNA | miR-145 | NA | Homo sapiens (human) | Cervical Cancer | 26311052 |
| MALAT1 | LncRNA | miR-145 | Ago2 | Homo sapiens (human) | Cervical Cancer | 26311052 |
| MALAT1 | LncRNA | miR-145 | TGFB1 | Homo sapiens (human) | Endothelial-To-Mesenchymal Transition | 28535533 |
| MALAT1 | LncRNA | miR-145 | TGFBR2 | Homo sapiens (human) | Endothelial-To-Mesenchymal Transition | 28535533 |
| MALAT1 | LncRNA | miR-145 | SMAD3 | Homo sapiens (human) | Endothelial-To-Mesenchymal Transition | 28535533 |
| MALAT1 | LncRNA | miR-145 | KLF4 | Homo sapiens (human) | Gastric Cancer | 29719612 |
| MALAT1 | LncRNA | miR-145 | SMAD3 | Homo sapiens (human) | Prostate Cancer | 34295718 |
| MALAT1 | LncRNA | miR-145 | TGFBR2 | Homo sapiens (human) | Prostate Cancer | 34295718 |
| MALAT1 | LncRNA | miR-145 | AQP4 | Mus musculus (mouse) | Cerebral Ischemia-Reperfusion Injury | 32138732 |
| MALAT1 | LncRNA | miR-145 | TGFB1 | Mus musculus (mouse) | Endothelial-To-Mesenchymal Transition | 28535533 |
| MALAT1 | LncRNA | miR-145 | TGFBR2 | Mus musculus (mouse) | Endothelial-To-Mesenchymal Transition | 28535533 |
| MALAT1 | LncRNA | miR-145 | SMAD3 | Mus musculus (mouse) | Endothelial-To-Mesenchymal Transition | 28535533 |
| NRP1 | LncRNA | miR-145 | DCBLD2 | Homo sapiens (human) | Bladder Cancer | 34249735 |
| OCT4-pg5 | Pseudogene | miR-145 | OCT4 | Homo sapiens (human) | Endometrial Cancer | 25634023 |
| PVT1 | Circular RNA | miR-145 | Talin1 | Homo sapiens (human) | Adenomyosis | 33728345 |
| SNHG1 | LncRNA | miR-145 | p70S6k | Homo sapiens (human) | Colorectal Cancer | 29416759 |
| SNHG1 | LncRNA | miR-145 | E2F3 | Homo sapiens (human) | Colorectal Cancer | 29416759 |
| SNHG14 | LncRNA | miR-145 | PI3K | Homo sapiens (human) | Gastric Cancer | 29667771 |
| SNHG14 | LncRNA | miR-145 | AKT | Homo sapiens (human) | Gastric Cancer | 29667771 |
| SNHG14 | LncRNA | miR-145 | mTOR | Homo sapiens (human) | Gastric Cancer | 29667771 |
| SOX21-AS1 | LncRNA | miR-145 | MYO6 | Homo sapiens (human) | Colorectal Cancer | 29217166 |
| TUG1 | LncRNA | miR-145 | ZEB2 | Homo sapiens (human) | Bladder Cancer | 26318860 |
| TUG1 | LncRNA | miR-145 | KLF4 | Homo sapiens (human) | Gastric Cancer | 29719612 |
| TUG1 | LncRNA | miR-145 | Sirt3 | Homo sapiens (human) | Intrahepatic Cholangiocarcinoma | 29371936 |
| TUG1 | LncRNA | miR-145 | ZEB1 | Homo sapiens (human) | Thyroid Cancer | 28645161 |
| UCA1 | LncRNA | miR-145 | FSCN1 | Homo sapiens (human) | Bladder Cancer | 26544536 |
| UCA1 | LncRNA | miR-145 | MYO6 | Mus musculus (mouse) | Gastric Cancer | 34238213 |
| ZNF609 | Circular RNA | miR-145 | STMN1 | Homo sapiens (human) | Nasopharyngeal Cancer | 33943007 |